History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy
Moreover, skeletal muscle injury models have suggested a beneficial effect not only for disturbances that occur as a result of direct trauma but also for systemic insults including hyperkalamia and hypermagnesia
Oral-specific risks are poorly characterized
Retrieved from Drugs..com
GIP receptor activation: Works synergistically with GLP-1 to improve glucose metabolism and enhance the satiety signal
The peptide also shows effectiveness for stubborn fat deposits in areas that resist traditional fat loss approaches